Transcription factor 7-like 2 (TCF7L2) regulates activin receptor-like kinase 1 (ALK1)/Smad1 pathway for development of diabetic nephropathy

Molecules and Cells

Volumn 30, Issue 3, 2010, Pages 209-218

  Araoka, Toshikazu ^a   Abe, Hideharu ^a   Tominaga, Tatsuya ^a   Mima, Akira ^a   Matsubara, Takeshi ^b   Murakami, Taichi ^a   Kishi, Seiji ^a   Nagai, Kojiro ^a   Doi, Toshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

ALK1; diabetic nephropathy; mesangial matrix expansion; Smad1; TCF7L2

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN RECEPTOR LIKE KINASE 1; ADVANCED GLYCATION END PRODUCT; ALPHA SMOOTH MUSCLE ACTIN; FIREFLY LUCIFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; RENILLA LUCIFERIN 2 MONOOXYGENASE; SMAD1 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HISTOLOGY; MALE; MESANGIUM CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TRANSIENT TRANSFECTION; WESTERN BLOTTING;

ACTIVIN RECEPTORS, TYPE II; ANIMALS; CELLS, CULTURED; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GLOMERULAR MESANGIUM; HUMANS; MESANGIAL CELLS; MICE; MICE, TRANSGENIC; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSCRIPTIONAL ACTIVATION; TRANSGENES;

MUS MUSCULUS;

EID: 78049255269     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-010-0109-9     Document Type: Article

References (52)

1. H. Abe T. Matsubara N. Iehara K. Nagai T. Takahashi H. Arai T. Kita T. Doi 2004 Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation J. Biol. Chem. 279 14201 14206 1:CAS:528:DC%2BD2cXis1eltb0%3D 10.1074/jbc.M310427200 14732718 (Pubitemid 38468958)
2. M. Bojestig H.J. Arnqvist G. Hermansson B.E. Karlberg J. Ludvigsson 1994 Declining incidence of nephropathy in insulin-dependent diabetes mellitus N. Engl. J. Med. 330 15 18 1:STN:280:DyaK2c%2FotFyksA%3D%3D 10.1056/ NEJM199401063300103 8259139 (Pubitemid 24018611)
3. M. Davies 1994 The mesangial cell: a tissue culture view Kidney Int 45 320 327 1:STN:280:DyaK2c3hslentQ%3D%3D 10.1038/ki.1994.41 8164415
4. T. Doi H. Vlassara M. Kirstein Y. Yamada G.E. Striker L.J. Striker 1992 Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor Proc. Natl. Acad. Sci. USA 89 2873 2877 1:CAS:528: DyaK38Xitlaktr4%3D 10.1073/pnas.89.7.2873 1313571
5. S.C. Elbein S.K. Das D.M. Hallman C.L. Hanis S.J. Hasstedt 2009 Genome-wide linkage and admixture mapping of type 2 diabetes in African American families from the American Diabetes Association GENNID (Genetics of NIDDM) Study Cohort Diabetes 58 268 274 1:CAS:528:DC%2BD1MXptVCnug%3D%3D 10.2337/db08-0931 18840782
6. M. Essawy O. Soylemezoglu E.C. Muchaneta-Kubara J. Shortland C.B. Brown A.M. el Nahas 1997 Myofibroblasts and the progression of diabetic nephropathy Nephrol. Dial. Transplant 12 43 50 1:STN:280:DyaK2s7nvFGitA%3D%3D 10.1093/ndt/12.1.43 9027772 (Pubitemid 27046200)
7. L. Fink W. Seeger L. Ermert J. Hanze U. Stahl F. Grimminger W. Kummer R.M. Bohle 1998 Real-time quantitative RT-PCR after laser-assisted cell picking Nat. Med. 4 1329 1333 1:CAS:528:DyaK1cXntlaru7s%3D 10.1038/3327 9809560 (Pubitemid 28512117)
8. K.W. Finnson W.L. Parker P. ten Dijke M. Thorikay A. Philip 2008 ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes J. Bone Miner. Res. 23 896 906 1:CAS:528: DC%2BD1cXnvVGjs7k%3D 10.1359/jbmr.080209 18333754 (Pubitemid 351768808)
9. J.C. Florez K.A. Jablonski N. Bayley T.I. Pollin P.I. de Bakker A.R. Shuldiner W.C. Knowler D.M. Nathan D. Altshuler 2006 TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program N. Engl. J. Med. 355 241 250 1:CAS:528:DC%2BD28XntVWktrw%3D 10.1056/NEJMoa062418 16855264 (Pubitemid 44079339)
10. H.C. Gerstein J.F. Mann Q. Yi B. Zinman S.F. Dinneen B. Hoogwerf J.P. Halle J. Young A. Rashkow C. Joyce, et al. 2001 Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 421 426 1:CAS:528:DC%2BD3MXlvFKksL0%3D 10.1001/jama.286.4. 421 11466120
11. A.S. Go G.M. Chertow D. Fan C.E. McCulloch C.Y. Hsu 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N. Engl. J. Med. 351 1296 1305 1:CAS:528:DC%2BD2cXnvFSgtr8%3D 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
12. M.J. Goumans G. Valdimarsdottir S. Itoh A. Rosendahl P. Sideras P. ten Dijke 2002 Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors EMBO J. 21 1743 1753 1:CAS:528:DC%2BD38XjtVOgtL8%3D 10.1093/emboj/21.7.1743 11927558 (Pubitemid 34614630)
13. S.F. Grant G. Thorleifsson I. Reynisdottir R. Benediktsson A. Manolescu J. Sainz A. Helgason H. Stefansson V. Emilsson A. Helgadottir, et al. 2006 Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes Nat. Genet. 38 320 323 1:CAS:528:DC%2BD28XhslCjtrw%3D 10.1038/ng1732 16415884
14. M.B. Hautmann C.S. Madsen G.K. Owens 1997 A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements J. Biol. Chem. 272 10948 10956 1:CAS:528:DyaK2sXivVSntrg%3D 10.1074/jbc.272.16.10948 9099754 (Pubitemid 27181115)
15. G.J. Inman F.J. Nicolas J.F. Callahan J.D. Harling L.M. Gaster A.D. Reith N.J. Laping C.S. Hill 2002 SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 Mol. Pharmacol. 62 65 74 1:CAS:528:DC%2BD38Xlt1Kqtb4%3D 10.1124/mol.62.1.65 12065756 (Pubitemid 34680517)
16. B. Isomaa P. Almgren T. Tuomi B. Forsen K. Lahti M. Nissen M.R. Taskinen L. Groop 2001 Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 683 689 1:STN:280:DC%2BD3MvjsVOqsw%3D%3D 10.2337/diacare.24.4.683 11315831
17. A. Kanematsu A. Ramachandran R.M. Adam 2007 GATA-6 mediates human bladder smooth muscle differentiation: involvement of a novel enhancer element in regulating alphasmooth muscle actin gene expression Am. J. Physiol. Cell Physiol. 293 C1093 1102 1:CAS:528:DC%2BD2sXhtVOqsb7I 10.1152/ajpcell.00225.2007 17626241 (Pubitemid 47437382)
18. Y.S. Kanwar J. Wada L. Sun P. Xie E.I. Wallner S. Chen S. Chugh F.R. Danesh 2008 Diabetic nephropathy: mechanisms of renal disease progression Exp. Biol. Med. 233 4 11 1:CAS:528:DC%2BD1cXhsVeqsw%3D%3D 10.3181/0705-MR-134
19. P.C. Keelan L.F. Bielak K. Ashai L.S. Jamjoum A.E. Denktas J.A. Rumberger I.P. Sheedy P.A. Peyser R.S. Schwartz 2001 Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography Circulation 104 412 417 1:STN:280: DC%2BD3MvitVemsw%3D%3D 10.1161/hc2901.093112 11468202
20. Konig, H.G., Kogel, D., Rami, A., and Prehn, J.H. (2005). TGF-ta1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling. J. Cell Biol. 168, 1077-1086.
21. V. Korinek N. Barker P.J. Morin D. van Wichen R. de Weger K.W. Kinzler B. Vogelstein H. Clevers 1997 Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma Science 275 1784 1787 1:CAS:528:DyaK2sXitVGksr8%3D 10.1126/science.275.5307.1784 9065401 (Pubitemid 27136714)
22. A. Kottgen S.J. Hwang E. Rampersaud J. Coresh K.E. North J.S. Pankow J.B. Meigs J.C. Florez A. Parsa D. Levy, et al. 2008 TCF7L2 variants associate with CKD progression and renal function in population-based cohorts J. Am. Soc. Nephrol. 19 1989 1999 10.1681/ASN.2007121291 18650481
23. I. Kou M. Nakajima S. Ikegawa 2007 Expression and regulation of the osteoarthritis-associated protein asporin J. Biol. Chem. 282 32193 32199 1:CAS:528:DC%2BD2sXht1Wls7zK 10.1074/jbc.M706262200 17804408 (Pubitemid 350106456)
24. Z. Liu J.F. Habener 2008 Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation J. Biol. Chem. 283 8723 8735 1:CAS:528:DC%2BD1cXjsFCgt7o%3D 10.1074/jbc.M706105200 18216022
25. R.X. Luo A.A. Postigo D.C. Dean 1998 Rb interacts with histone deacetylase to repress transcription Cell 92 463 473 1:CAS:528: DyaK1cXhsVKnsb8%3D 10.1016/S0092-8674(00)80940-X 9491888 (Pubitemid 28101110)
26. A. Lux L. Attisano D.A. Marchuk 1999 Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1 J. Biol. Chem. 274 9984 9992 1:CAS:528:DyaK1MXis1Gjsbw%3D 10.1074/jbc.274.15.9984 10187774 (Pubitemid 29180861)
27. V. Lyssenko R. Lupi P. Marchetti S. Del Guerra M. Orho-Melander P. Almgren M. Sjogren C. Ling K.F. Eriksson A.L. Lethagen, et al. 2007 Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes J. Clin. Invest. 117 2155 2163 1:CAS:528:DC%2BD2sXoslOnsrk%3D 10.1172/JCI30706 17671651 (Pubitemid 47219560)
28. T. Matsubara H. Abe H. Arai K. Nagai A. Mima H. Kanamori E. Sumi T. Takahashi M. Matsuura N. Iehara, et al. 2006 Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy Lab. Invest. 86 357 368 1:CAS:528:DC%2BD28Xis1Grsbc%3D 10.1038/labinvest.3700400 16482100
29. A. Mima H. Arai T. Matsubara H. Abe K. Nagai Y. Tamura K. Torikoshi M. Araki H. Kanamori T. Takahashi, et al. 2008 Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy Diabetes 57 1712 1722 1:CAS:528:DC%2BD1cXnsF2is7c%3D 10.2337/db07-1726 18285555
30. T. Nakamura M. Fukui I. Ebihara S. Osada I. Nagaoka Y. Tomino H. Koide 1993 mRNA expression of growth factors in glomeruli from diabetic rats Diabetes 42 450 456 1:CAS:528:DyaK3sXksVKksro%3D 10.2337/diabetes.42.3.450 8094359 (Pubitemid 23066522)
31. S.P. Oh T. Seki K.A. Goss T. Imamura Y. Yi P.K. Donahoe L. Li K. Miyazono P. ten Dijke S. Kim, et al. 2000 Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis Proc. Natl. Acad. Sci. USA 97 2626 2631 1:CAS:528:DC%2BD3cXitVaiu7Y%3D 10.1073/pnas.97.6.2626 10716993 (Pubitemid 30159221)
32. I.S. Park H. Kiyomoto S.L. Abboud H.E. Abboud 1997 Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes Diabetes 46 473 480 1:CAS:528:DyaK2sXhsVKjt70%3D 10.2337/diabetes.46.3.473 9032105
33. L.E. Parton P.J. McMillen Y. Shen E. Docherty E. Sharpe F. Diraison C.P. Briscoe G.A. Rutter 2006 Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis Am. J. Physiol. Endocrinol. Metab. 291 E982 994 1:CAS:528:DC%2BD28Xht1Gns7bJ 10.1152/ajpendo.00067.2006 16772326 (Pubitemid 44794221)
34. M.M. Sale S.G. Smith J.C. Mychaleckyj K.L. Keene C.D. Langefeld T.S. Leak P.J. Hicks D.W. Bowden S.S. Rich B.I. Freedman 2007 Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy Diabetes 56 2638 2642 1:CAS:528:DC%2BD2sXhtFygt73F 10.2337/db07-0012 17601994 (Pubitemid 47523273)
35. T. Sanai T. Sobka T. Johnson M. el-Essawy E.C. Muchaneta-Kubara O. Ben Gharbia S. el Oldroyd A.M. Nahas 2000 Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy Diabetologia 43 91 100 1:CAS:528:DC%2BD3cXjs1Cjuw%3D%3D 10.1007/s001250050012 10663221
36. B.F. Schrijvers A.S. De Vriese A. Flyvbjerg 2004 From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines Endocr. Rev. 25 971 1010 1:CAS:528:DC%2BD2MXjslWntw%3D%3D 10.1210/er.2003-0018 15583025 (Pubitemid 39657775)
37. T. Shimokawa Y. Furukawa M. Sakai M. Li N. Miwa Y.M. Lin Y. Nakamura 2003 Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex Cancer Res. 63 6116 6120 1:CAS:528:DC%2BD3sXotV2jtL0%3D 14559787
38. L. Shu N.S. Sauter F.T. Schulthess A.V. Matveyenko J. Oberholzer K. Maedler 2008 Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets Diabetes 57 645 653 1:CAS:528: DC%2BD1cXjt1Chtbo%3D 10.2337/db07-0847 18071026
39. M. Sjogren V. Lyssenko A. Jonsson G. Berglund P. Nilsson L. Groop M. Orho-Melander 2008 The search for putative unifying genetic factors for components of the metabolic syndrome Diabetologia 51 2242 2251 1:STN:280:DC%2BD1cjhvF2isA%3D%3D 10.1007/s00125-008-1151-4 18853134
40. T. Takamura I. Kato N. Kimura T. Nakazawa H. Yonekura S. Takasawa H. Okamoto 1998 Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis J. Biol. Chem. 273 2493 2496 1:CAS:528:DyaK1cXnvFShsw%3D%3D 10.1074/jbc.273.5.2493 9446547 (Pubitemid 28133886)
41. Y. Tang S. Urs L. Liaw 2008 Hairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site Circ. Res. 102 661 668 1:CAS:528:DC%2BD1cXjs1Wmsbc%3D 10.1161/CIRCRESAHA.107.165134 18239137 (Pubitemid 351457858)
42. R.C. Trembath J.R. Thomson R.D. Machado N.V. Morgan C. Atkinson I. Winship G. Simonneau N. Galie J.E. Loyd M. Humbert, et al. 2001 Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia N. Engl. J. Med. 345 325 334 1:CAS:528: DC%2BD3MXmtVGqs7Y%3D 10.1056/NEJM200108023450503 11484689 (Pubitemid 32703235)
43. L.D. Urness L.K. Sorensen D.Y. Li 2000 Arteriovenous malformations in mice lacking activin receptor-like kinase-1 Nat. Genet. 26 328 331 1:CAS:528:DC%2BD3cXotVWhsb0%3D 10.1038/81634 11062473
44. S. Wang R. Hirschberg 2009 Diabetes-relevant regulation of cultured blood outgrowth endothelial cells Microvasc. Res. 78 174 179 10.1016/j.mvr.2009.06. 002 19539633
45. D. Warodomwichit D.K. Arnett E.K. Kabagambe M.Y. Tsai J.E. Hixson R.J. Straka M. Province P. An C.Q. Lai I. Borecki, et al. 2009 Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia J. Nutr. 139 439 446 1:CAS:528:DC%2BD1MXjsFKitLY%3D 10.3945/jn.108.096461 19141698
46. M.L. Waterman 2004 Lymphoid enhancer factor/T cell factor expression in colorectal cancer Cancer Metastasis Rev. 23 41 52 1:CAS:528:DC%2BD3sXnsFansro%3D 10.1023/A:1025858928620 15000148 (Pubitemid 38228369)
47. M.N. Weedon K.R. Owen B. Shields G. Hitman M. Walker M.I. McCarthy A.T. Hattersley T.M. Frayling 2005 A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population Diabetes 54 2487 2491 1:CAS:528:DC%2BD2MXnt1yntLw%3D 10.2337/diabetes.54.8.2487 16046319 (Pubitemid 41134280)
48. E. Wiercinska L. Wickert B. Denecke H.M. Said J. Hamzavi A.M. Gressner M. Thorikay P. ten Dijke P.R. Mertens K. Breitkopf, et al. 2006 Id1 is a critical mediator in TGF-betainduced transdifferentiation of rat hepatic stellate cells Hepatology 43 1032 1041 1:CAS:528:DC%2BD28XkvFGmtLw%3D 10.1002/hep.21135 16628634 (Pubitemid 43738969)
49. S. Yamagishi Y. Inagaki T. Okamoto S. Amano K. Koga M. Takeuchi Z. Makita 2002 Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells J. Biol. Chem. 277 20309 20315 1:CAS:528:DC%2BD38XkslWgtrs%3D 10.1074/jbc.M202634200 11912219 (Pubitemid 34967325)
50. Y. Yamamoto I. Kato T. Doi H. Yonekura S. Ohashi M. Takeuchi T. Watanabe S. Yamagishi S. Sakurai S. Takasawa, et al. 2001 Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice J. Clin. Invest. 108 261 268 1:CAS:528:DC%2BD3MXlt1Kltrw%3D 11457879
51. Y. Yao A.F. Zebboudj A. Torres E. Shao K. Bostrom 2007 Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular mesenchymal cells Cardiovasc. Res. 74 279 289 1:CAS:528:DC%2BD2sXjvFehsLY%3D 10.1016/j.cardiores.2006.09.014 17074310 (Pubitemid 46517503)
52. F.N. Ziyadeh 2004 Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator J. Am. Soc. Nephrol. 15 S55 S57 1:CAS:528:DC%2BD3sXps1Sitbs%3D 10.1097/01.ASN.0000093460.24823.5B 14684674